Using routine blood parameters to anticipate clinical outcomes in invasive aspergillosis.

Date publication

octobre 2019

Journal

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases

Auteurs

Membres identifiés du Cancéropôle Est :
Pr HERBRECHT Raoul

Tous les auteurs :
Pang L, Zhao X, Dickens BL, Lim JT, Cook AR, Netea MG, Donnelly JP, Herbrecht R, Johnson EM, Maertens JA, Kullberg BJ, Troke PF, Marr KA, Chai LYA

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/31669427

Résumé

In invasive aspergillosis (IA), monitoring response to anti-fungal treatment is challenging. We aimed to explore if routine blood parameters help to anticipate outcomes following IA.

Mots clés

C reactive protein, Creatinine, Galactomannan, Leukemia, Platelet, Survival

Référence

Clin. Microbiol. Infect.. 2019 Oct 24;: